Novo Ventures Investments & Fund Profile

Overview

Investment and venture capital in life sciences and financial assets.

Founded

1999

Deals · 12mo

0

Links

Website

Stage focus

Series A

Series B

Geographic focus

Switzerland

United Kingdom

United States

Sector focus

Asset Management

Finance

Social

Investment portfolio

41rounds

LedParticipated

NAME	DATE	SIZE
INBRACE	Sep 2021Participated	$102 MSeries D
Reneo Pharmaceuticals	Dec 2020Led	$95 MSeries B
Lava Therapeutics	Sep 2020Led	$84 MSeries C
NodThera	Jun 2020Participated	$55 MSeries B
Anokion	Sep 2019Participated	$40 MSeries B
Amolyt Pharma	Jul 2019Participated	$75 MSeries A
Galera Therapeutics	Sep 2018Participated	$70 MSeries C
ReViral	Aug 2018Led	$55 MSeries B
Inozyme	Nov 2017Participated	$49 MSeries A
Unchained Labs	Jun 2017Participated	$13 MSeries C
Galera Therapeutics	Nov 2016Participated	$15 MSeries B
Arch Oncology	Aug 2016Led	$86 MSeries A
INBRACE	Sep 2021Participated	$102 MSeries D
Reneo Pharmaceuticals	Dec 2020Led	$95 MSeries B
Lava Therapeutics	Sep 2020Led	$84 MSeries C
NodThera	Jun 2020Participated	$55 MSeries B
Anokion	Sep 2019Participated	$40 MSeries B
Amolyt Pharma	Jul 2019Participated	$75 MSeries A
Galera Therapeutics	Sep 2018Participated	$70 MSeries C
ReViral	Aug 2018Led	$55 MSeries B
Inozyme	Nov 2017Participated	$49 MSeries A
Unchained Labs	Jun 2017Participated	$13 MSeries C
Galera Therapeutics	Nov 2016Participated	$15 MSeries B
Arch Oncology	Aug 2016Led	$86 MSeries A

41 Items

41

Items

...

Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Novo Ventures: 41 funding rounds are recorded in the selected participation categories. All available history
Round type	Led deals	Participated deals
Series A	6	4
Series B	11	7
Series C+	3	6
Other Equity	0	4

Monthly Deal Activity

Novo Ventures: 41 deals are recorded across 202 months. All available history
Month	Deals
Jan '10	2
Feb '10	0
Mar '10	0
Apr '10	0
May '10	1
Jun '10	1
Jul '10	0
Aug '10	1
Sep '10	0
Oct '10	0
Nov '10	0
Dec '10	0
Jan '11	0
Feb '11	0
Mar '11	0
Apr '11	2
May '11	1
Jun '11	0
Jul '11	0
Aug '11	0
Sep '11	0
Oct '11	1
Nov '11	0
Dec '11	0
Jan '12	1
Feb '12	0
Mar '12	0
Apr '12	1
May '12	0
Jun '12	0
Jul '12	0
Aug '12	0
Sep '12	0
Oct '12	1
Nov '12	0
Dec '12	2
Jan '13	1
Feb '13	0
Mar '13	1
Apr '13	0
May '13	0
Jun '13	0
Jul '13	0
Aug '13	0
Sep '13	1
Oct '13	0
Nov '13	0
Dec '13	0
Jan '14	0
Feb '14	1
Mar '14	0
Apr '14	3
May '14	1
Jun '14	0
Jul '14	0
Aug '14	0
Sep '14	1
Oct '14	0
Nov '14	0
Dec '14	0
Jan '15	1
Feb '15	1
Mar '15	0
Apr '15	0
May '15	0
Jun '15	0
Jul '15	1
Aug '15	0
Sep '15	1
Oct '15	1
Nov '15	1
Dec '15	0
Jan '16	0
Feb '16	0
Mar '16	0
Apr '16	0
May '16	0
Jun '16	0
Jul '16	0
Aug '16	1
Sep '16	0
Oct '16	0
Nov '16	1
Dec '16	0
Jan '17	0
Feb '17	0
Mar '17	0
Apr '17	0
May '17	0
Jun '17	1
Jul '17	0
Aug '17	0
Sep '17	0
Oct '17	0
Nov '17	1
Dec '17	0
Jan '18	0
Feb '18	0
Mar '18	0
Apr '18	0
May '18	0
Jun '18	0
Jul '18	0
Aug '18	1
Sep '18	1
Oct '18	0
Nov '18	0
Dec '18	0
Jan '19	0
Feb '19	0
Mar '19	0
Apr '19	0
May '19	0
Jun '19	0
Jul '19	1
Aug '19	0
Sep '19	1
Oct '19	0
Nov '19	0
Dec '19	0
Jan '20	0
Feb '20	0
Mar '20	0
Apr '20	0
May '20	0
Jun '20	1
Jul '20	0
Aug '20	0
Sep '20	1
Oct '20	0
Nov '20	0
Dec '20	1
Jan '21	0
Feb '21	0
Mar '21	0
Apr '21	0
May '21	0
Jun '21	0
Jul '21	0
Aug '21	0
Sep '21	1
Oct '21	0
Nov '21	0
Dec '21	0
Jan '22	0
Feb '22	0
Mar '22	0
Apr '22	0
May '22	0
Jun '22	0
Jul '22	0
Aug '22	0
Sep '22	0
Oct '22	0
Nov '22	0
Dec '22	0
Jan '23	0
Feb '23	0
Mar '23	0
Apr '23	0
May '23	0
Jun '23	0
Jul '23	0
Aug '23	0
Sep '23	0
Oct '23	0
Nov '23	0
Dec '23	0
Jan '24	0
Feb '24	0
Mar '24	0
Apr '24	0
May '24	0
Jun '24	0
Jul '24	0
Aug '24	0
Sep '24	0
Oct '24	0
Nov '24	0
Dec '24	0
Jan '25	0
Feb '25	0
Mar '25	0
Apr '25	0
May '25	0
Jun '25	0
Jul '25	0
Aug '25	0
Sep '25	0
Oct '25	0
Nov '25	0
Dec '25	0
Jan '26	0
Feb '26	0
Mar '26	0
Apr '26	0
May '26	0
Jun '26	0
Jul '26	0
Aug '26	0
Sep '26	0
Oct '26	0

Sector Breakdown

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Novo Ventures: Health & Life Sciences is the largest displayed sector by deal count (41 deals). All available history
Sector	Deals
Health & Life Sciences	41
Consumer & Lifestyle	3
Networks, Cloud & Communication	1
Manufacturing	1

Deal Size Distribution

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Novo Ventures: 41 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)	Deals
<$5M	0
$5M-$10M	0
$10M-$25M	10
$25M-$50M	20
$50M-$100M	10
$100M-$250M	1
$250M-$500M	0
$500M-$1B	0
$1B+	0

Deals By Geography

Top 2 of 2 regions; European countries are grouped as Europe.

Novo Ventures: United States has the largest recorded deal count among the displayed regions (31 deals). All available history
Region	Deals
United States	31
Europe	10

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Novo Ventures: 20 co-investors are shown, with Novartis sharing 9 recorded deals. All available history
Co-investor	Shared deals
Novartis	9
New Enterprise Associates	8
RiverVest Venture Partners	7
TPG Biotech	7
OrbiMed	6
Roche Venture	5
Rock Springs Capital	5
Versant Ventures	5
Domain Associates	4
F-Prime Capital	4
SR One	4
SV Health Investors	4
Alta Partners	3
Avalon Ventures	3
Canaan Partners	3
Correlation Ventures	3
Galera Angels	3
HBM Healthcare Investments	3
Sofinnova Partners	3
Sofinnova Ventures	3